JP2010163421A5 - - Google Patents

Download PDF

Info

Publication number
JP2010163421A5
JP2010163421A5 JP2009208631A JP2009208631A JP2010163421A5 JP 2010163421 A5 JP2010163421 A5 JP 2010163421A5 JP 2009208631 A JP2009208631 A JP 2009208631A JP 2009208631 A JP2009208631 A JP 2009208631A JP 2010163421 A5 JP2010163421 A5 JP 2010163421A5
Authority
JP
Japan
Prior art keywords
medical
dental material
material according
bone formation
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009208631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010163421A (ja
JP4801193B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2009208631A external-priority patent/JP4801193B2/ja
Priority to JP2009208631A priority Critical patent/JP4801193B2/ja
Priority to PCT/JP2009/071231 priority patent/WO2010071217A1/ja
Priority to KR1020117016671A priority patent/KR101314995B1/ko
Priority to EP09833518.5A priority patent/EP2377545A4/en
Priority to US13/140,931 priority patent/US9486496B2/en
Priority to TW098143881A priority patent/TWI400083B/zh
Publication of JP2010163421A publication Critical patent/JP2010163421A/ja
Publication of JP2010163421A5 publication Critical patent/JP2010163421A5/ja
Publication of JP4801193B2 publication Critical patent/JP4801193B2/ja
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009208631A 2008-12-19 2009-09-09 骨形成用の医療用または歯科用材料 Expired - Fee Related JP4801193B2 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2009208631A JP4801193B2 (ja) 2008-12-19 2009-09-09 骨形成用の医療用または歯科用材料
US13/140,931 US9486496B2 (en) 2008-12-19 2009-12-21 Anti periodontitis-causing microorganism agent and medical or dental materials using the same
KR1020117016671A KR101314995B1 (ko) 2008-12-19 2009-12-21 항치주병균제 및 그것을 사용한 의료용 또는 치과용 재료
EP09833518.5A EP2377545A4 (en) 2008-12-19 2009-12-21 ANTIBACTERIC AGAINST BACTERIA AS CAUSE OF DENTISTRY DISEASES AND MEDICINE BZW. DENTAL MATERIAL THEREFOR
PCT/JP2009/071231 WO2010071217A1 (ja) 2008-12-19 2009-12-21 抗歯周病菌剤及びそれを用いた医療用または歯科用材料
TW098143881A TWI400083B (zh) 2008-12-19 2009-12-21 醫療用或牙科用材料

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008324524 2008-12-19
JP2008324524 2008-12-19
JP2009208631A JP4801193B2 (ja) 2008-12-19 2009-09-09 骨形成用の医療用または歯科用材料

Publications (3)

Publication Number Publication Date
JP2010163421A JP2010163421A (ja) 2010-07-29
JP2010163421A5 true JP2010163421A5 (enExample) 2011-04-14
JP4801193B2 JP4801193B2 (ja) 2011-10-26

Family

ID=42268883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009208631A Expired - Fee Related JP4801193B2 (ja) 2008-12-19 2009-09-09 骨形成用の医療用または歯科用材料

Country Status (6)

Country Link
US (1) US9486496B2 (enExample)
EP (1) EP2377545A4 (enExample)
JP (1) JP4801193B2 (enExample)
KR (1) KR101314995B1 (enExample)
TW (1) TWI400083B (enExample)
WO (1) WO2010071217A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5467800B2 (ja) * 2009-05-14 2014-04-09 ロート製薬株式会社 唾液分泌促進剤及び唾液分泌促進用組成物
US10166313B2 (en) 2013-09-25 2019-01-01 Maruha Nichiro Corporation Medical or dental material for osteogenesis
DE112015004182T5 (de) * 2014-09-12 2018-01-11 Maruha Nichiro Corporation Antimykotische Zusammensetzung umfassend antimykotisches Peptid und Terpenalkohol
CN108721135A (zh) * 2017-04-21 2018-11-02 学校法人明治大学 具有牙本质小管封闭性的牙处置用材料
CN114028606B (zh) * 2021-10-26 2023-06-13 湘雅生物医药(湖州)有限公司 一种壳聚糖、鱼精蛋白抗菌止血微球及其制备方法
WO2025110384A1 (ko) * 2023-11-24 2025-05-30 정인선 항균성 및 중합깊이가 향상된 심미수복용 복합레진 및 항균 및 항바이러스성 3d 프린팅 의치상용 레진 조성물, 그리고 이들의 제조 방법

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61115030A (ja) * 1984-11-07 1986-06-02 Lion Corp 骨疾患治療剤
JPH0755235B2 (ja) * 1986-09-08 1995-06-14 新田ゼラチン株式会社 骨形成用注入材料
JPS6434371A (en) * 1987-07-31 1989-02-03 Nitta Gelatin Kk Periosteal bone forming material
JPH01202072A (ja) * 1988-02-08 1989-08-15 Toshiba Corp ノイズリデューサ回路
JPH01207072A (ja) * 1988-02-15 1989-08-21 Yasumasa Otori 骨形成材料およびその製法
JPH02241460A (ja) * 1989-03-16 1990-09-26 Asahi Optical Co Ltd 骨修復用複合材料
JPH08239398A (ja) 1995-03-03 1996-09-17 Sogo Yatsukou Kk 水不溶性、自己支持性透明dna・脂質複合体フィルムおよびその製造方法
JP3873429B2 (ja) 1998-02-20 2007-01-24 大鵬薬品工業株式会社 ペプチド誘導体及びその薬学的に許容される塩、その製造方法及びその用途
JP2001089436A (ja) 1999-09-20 2001-04-03 Sagami Chem Res Center アルギニン誘導体、アルギンギパイン阻害剤、及び抗歯周病剤
JP2001327591A (ja) * 2000-03-13 2001-11-27 Shigeo Okahata 医療用または歯科用材料およびその製造方法
JP2001321123A (ja) * 2000-05-15 2001-11-20 Takeshi Inoi 抗う蝕性食品素材、およびその組成物
JP2002060341A (ja) * 2000-08-21 2002-02-26 Terumo Corp 止血剤
US7204874B2 (en) * 2001-10-24 2007-04-17 Pentron Clinical Technologies, Llc Root canal filling material
JP4674288B2 (ja) * 2004-03-31 2011-04-20 恵雄 岡畑 歯科用材料。
US7758892B1 (en) * 2004-05-20 2010-07-20 Boston Scientific Scimed, Inc. Medical devices having multiple layers
US20080139450A1 (en) * 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
AU2006265707B2 (en) 2005-07-01 2012-06-14 Kane Biotech Inc. Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices
JP4354445B2 (ja) * 2005-10-05 2009-10-28 恵雄 岡畑 Dna/キトサン複合体の成形方法
JP2007169201A (ja) 2005-12-21 2007-07-05 Lion Corp 口腔用組成物
JP4718416B2 (ja) * 2006-10-31 2011-07-06 忠男 福島 Dnaとポリカチオンの複合体からのフィルムの製造方法
JP4520477B2 (ja) 2006-10-31 2010-08-04 株式会社マルハニチロ食品 抗真菌ペプチドまたはそれを含有するペプチド組成物とその製造方法

Similar Documents

Publication Publication Date Title
JP2009256391A5 (enExample)
HRP20190031T1 (hr) Sintetski triterpenoidi i postupci njihove upotrebe u liječenju bolesti
JP2011510093A5 (ja) 口腔ケア製品ならびにその使用および製造の方法
JP2010163421A5 (enExample)
IL217540A (en) An oral preparation for use in oral disinfection or in the treatment of oral diseases
JP2010525055A5 (enExample)
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
PT2291394T (pt) Proteínas de fusão e seus usos no diagnóstico e tratamento de leishmaniose
JP2009039101A5 (enExample)
BRPI0907102A2 (pt) composição dental, e, método para eliminar ou reduzir o desconforto e a dor associados com a hipersensibilidade da dentina
ZA201403596B (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
ZA201003688B (en) Arginine salts and their uses for thr treatment of illnesses in the oral cavity
EP2051658A4 (en) COMPOUND IMPLANTS FOR PROMOTING BONE REGENERATION AND REINFORCEMENT AND METHOD FOR THEIR PRODUCTION AND USE
IL212568A (en) Annotated 4,1-Diazepan, Pharmaceutical Preparations Containing Them and Their Uses in the Preparation of Medicines for the Treatment of Diseases or Disorders of Mammals
ZA201001118B (en) Prosthesis for promoting the in vivo reconstruction of a hollow organ or a portion of a hollow organ
ATE530575T1 (de) Demannosylierter rekombinanter faktor viii zur behandlung von patienten mit hämophilie a
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
PL2318062T3 (pl) Nowe biomateriały, ich przygotowywanie przez elektrowirowanie i stosowanie w dziedzinach biomedycznych i chirurgicznych
IL210204A (en) Ligand, a method for its preparation, an antibody and a pharmaceutical composition containing it and their use in the preparation of a drug for the treatment of MSRV-related disease
BR112013004529A2 (pt) composição termogel biocompativel metodo para preparar uma composição termogel biocompativel de quitosana metodo para tratar ,reparar regenerar substituir ou trocar um tecido ou orgão dentro de um corpo mamifero ou humano e uso da composição
IL215840A (en) Arylsulfonamide compounds are converted into two positions 2 and 5, their pharmaceutical composition containing them and their use in the treatment of ccr3-related diseases
EP2212325A4 (en) 2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR SALTS THEREOF, PREPARATION PROCESS OF THE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
IL205290A (en) A variant of human neurorthin protein, or its active biological part, containing medicinal preparations, and its use in the preparation of therapeutic drugs
EP2502989A4 (en) IMPLANT COMPOSITION FOR THE REGENERATION OF NEURAL TISSUE, PREPARATION METHOD AND USES THEREOF